Total Funding
9
Total FundingSeries A raised
Growth Score
pts
Heat Score
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
144878
Ambys Medicines is a biotechnology company focused on discovering and developing regenerative and restorative therapies.
- Holger Willenbring: Co-Founder and Managing Director
Alan Smith: Chief Technology OfficerPast Role: Akouos, Chief Technology Officer
About the Company
Ambys Medicines is a biotechnology company focused on discovering and developing regenerative and restorative therapies. Ambys Medicines is working to fundamentally transform the lives of people suffering from severe liver diseases by creating breakthrough therapies capable of restoring liver function, preventing the progression of liver disease,
and treating the devastating complications of liver failure.
